Human growth hormone release: relation to slow-wave sleep and sleep-walking cycles

Two anti-anxiety drugs: a psychoneuroendocrine study

Eight males were studied during 27 weeks, including two periods of five weeks during which they received clinical doses of sodium amylobarbitone and benzoctamine. Substitution of placebo for either drug caused raised anxiety and impairment of mental concentration. The drugs reduced restlessness during sleep and reduced paradoxical sleep. By the fifth week of sodium amylobarbitone, although sleep was still less restless in the early night it was more restless than normal in the late night.Blood samples were taken half-hourly during sleep by indwelling venous catheter. Plasma growth hormone concentration was little affected during drug administration but rose temporarily after withdrawal. There was a reduction of plasma corticosteroid concentration during sleep throughout administration of the drugs and a rebound above normal during the first withdrawal week.

Nyctohemeral growth hormone levels in children with growth retardation and inflammatory bowel disease

Short stature is a common complication of inflammatory bowel disease. Recently McCaffery, Nasr, Lawrence, and Kirsner (1970) concluded, from blood growth hormone (GH) levels obtained during insulin-hypoglycaemic provocation, that GH deficiency contributed to the retardation in growth observed in subjects with inflammatory bowel disease. Although it was not possible to eliminate the possibility of partial hypopituitarism, this study does not confirm the existence of GH deficiency in six subjects with short stature complicating inflammatory bowel disease. The nyctohemeral (night and day) serum GH is described, and the insulin and glucose levels in these subjects and normal sleep-related GH rises in all are demonstrated. This finding is not compatible with growth hormone deficiency. In one subject the response to arginine provocation was blunted. Three subjects manifested hyperinsulinism and evidence for ;insulin resistance'. These findings are unexplained but suggest that insulin resistance may contribute to a blunted GH response to insulin-induced hypoglycaemia. Blunted GH response to both arginine and insulin-induced hypoglycaemia may also result from continuous secretion and reduced pituitary storage of growth hormone. This possibility is suggested by the pattern of raised blood GH levels in one of the subjects.

Relationship between sleep and growth in patients with reversible somatotropin deficiency (psychosocial dwarfism)

In a partly retrospective, partly follow-up study, 27 patients aged 1 year 10 months to 16 years 2 months with reversible somatotropin deficiency, showed a relationship between the rate of statural growth and sleep, graded as good, poor, or mixed. During periods of good sleep the overall growth rate averaged 1·04 cm per month, and during periods of poor sleep it averaged 0·34 cm per month (t=8·46, df=32, P<0·001). Presumably, good growth, good sleep, and optimal nocturnal somatotropin release intercorrelate in this syndrome of dwarfism, but the data with regard to nocturnal somatotropin release remain to be demonstrated empirically.

Human prolactin: 24-hour pattern with increased release during sleep

Human prolactin was measured in plasma by radioimmunoassay at 20 minute intervals for a 24-hour period in each of six normal adults, whose sleep-wake cycles were monitored polygraphically. A marked diurnal variation in plasma concentrations was demonstrated, with highest values during sleep; periods of episodic release occurred throughout the 24 hours.

Primary anorexia nervosa or weight phobia in the male: report on 13 cases

The cases of 13 men with anorexia nervosa are reported. While the disorder as seen in the clinic is much less common in males than females this may not be a true reflection of the differential sex or overall prevalence rates. The disorder is found to have the same basic characteristics in the male as in the female: namely, a phobic avoidance of normal weight associated with elective carbohydrate starvation and emaciation. As in the female the mechanism appears to develop out of normal adolescent dieting behaviour and to arise as a means of avoiding overwhelming psychosocial maturational demands of adolescence. Premorbid and family features include a state of overnutrition and a high degree of family psychopathology reflected in high rates of parental psychiatric morbidity and marital difficulty.

Gonadotropin secretion during sleep in normal adult men

Release of luteinizing hormone and follicle stimulating hormone during sleep in young adult men occurred in unrelated, random, arrhythmic peaks, with no consistency from night to night in the same subject. Release of luteinizing hormone was modestly but significantly larger (14 perecnt) during rapid-eye-movement sleep than it was in non-REM sleep, but release of follicle stimulating hormone was not clearly related to stages of sleep.

Chronic fenfluramine administration: some cerebral effects

Human cerebral function was monitored electrophysiologically during sleep over a period of months before, during, and after the intake of fenfluramine, 40-120 mg/day. Effects included dose-related reduction of paradoxical sleep, increase of intra-sleep restlessness, and changes in E.E.G. slow-wave sleep. It is hypothesized that weight loss may be associated with increase of the last. Grinding of teeth (bruxism) also was noted.Long-term studies make it possible to demonstrate changing central effects with time, including tolerance phenomena. Withdrawal abnormalities are related to the time taken for the drug to be eliminated-in the present case reaching a maximum four days after withdrawal.

The relationship between sleep, nutrition and mood: a study of patients with anorexia nervosa

An initial observation that insomnia, especially early morning waking, is a feature of anorexia nervosa has been confirmed. A further proposition that the insomnia is more closely related to the nutritional disturbance than to the mood state has also been confirmed using standardized measures of weight, sleep and mood. These findings are discussed in terms of the possible relevance to other illnesses involving weight change in which there is an alteration of sleep patterns.